What is the normal dose of guanfacine for a 9-year-old child with oppositional defiant disorder (ODD) and irritability?

Guanfacine Dosing for a 9-Year-Old with ODD and Irritability

For a 9-year-old child with ODD and irritability, start guanfacine extended-release at 1 mg once daily, then titrate by 1 mg weekly based on response and tolerability, targeting a weight-based dose of approximately 0.05-0.12 mg/kg/day (typically 2-4 mg/day for this age). 1, 2

Dosing Algorithm

Starting dose:

• Begin with 1 mg once daily (preferably at bedtime to minimize somnolence) 1, 2

Titration schedule:

• Increase by 1 mg per week based on response and tolerability 2
• Use the rule of thumb: 0.1 mg/kg once daily for weight-based dosing 1

Target dose range:

• 0.05-0.12 mg/kg/day or 1-7 mg/day 2
• For a typical 9-year-old (approximately 30 kg), this translates to 2-3 mg/day
• Maximum dose: 4 mg/day 1

Time to effect:

• Allow 2-4 weeks to observe treatment effects 1
• This is substantially longer than stimulants, which have rapid onset

Evidence for ODD and Irritability

The evidence specifically supports guanfacine's efficacy for oppositional symptoms and irritability in children with ADHD. In a randomized, double-blind, placebo-controlled trial of children aged 6-12 with ADHD and oppositional symptoms, guanfacine XR produced significant reductions in oppositional behavior (effect size = 0.59, p<0.001) on the Conners' Parent Rating Scale oppositional subscale. 3 The mean reduction was 10.9 points with guanfacine versus 6.8 with placebo.

When used adjunctively with psychostimulants in children with suboptimal response, guanfacine produced placebo-adjusted reductions of -2.4 (p=0.001) on oppositional symptoms, with even greater effects (-3.6, p=0.001) in those with significant baseline oppositional symptoms. 4

Important Clinical Considerations

Common adverse effects to monitor:

• Somnolence/sedation (most common, occurring in 50-63% of patients) 3
• Fatigue (11%) 1
• Irritability (paradoxically can occur) 1
• Headache (22%) 3
• Upper abdominal pain (12%) 3

Critical safety monitoring:

• Blood pressure and pulse (guanfacine causes hypotension and bradycardia) 1, 5
• Obtain baseline cardiovascular history and vital signs before starting 5
• Monitor vital signs during titration and at steady state

Discontinuation warning:

• Never abruptly discontinue guanfacine - taper over at least 1 week to avoid rebound hypertension 1, 5
• Rebound occurs 2-4 days after abrupt cessation 6

Timing Strategy

Evening dosing is preferable to minimize daytime somnolence, which is the most common adverse effect. 3 Most sedation occurs during dose titration, and approximately 63.5% of sedation events resolve before completing treatment. 3

Context for ODD Treatment

While guanfacine is FDA-approved for ADHD (not specifically ODD), the evidence demonstrates clear benefits for oppositional symptoms and irritability. 4, 3 Guanfacine has particular advantages as a first-line option when comorbid sleep disorders, tic disorders, or substance use concerns exist, or when stimulants are contraindicated. 1

The effect size for guanfacine on ADHD symptoms is smaller than stimulants (medium vs. large effect sizes), but it provides "around-the-clock" coverage and is not a controlled substance. 1